Luteal phase consequences of low-dose gonadotropin-releasing hormone agonist therapy in nonluteal-supported in vitro fertilization cycles**Supported in part by the Vicksburg Hospital Medical Foundation, Vicksburg, Mississippi.
Long, Cecil A., Sopelak, Victoria M., Lincoln, Stephen R., Cowan, Bryan D.Volume:
64
Language:
english
Journal:
Fertility and Sterility
DOI:
10.1016/s0015-0282(16)57795-4
Date:
September, 1995
File:
PDF, 612 KB
english, 1995